Gene Therapies Pose Unprecedented Cost Concerns in Health Care

Submitted by onc_editor on Tue, 11/21/2017 - 18:42




Journal of Clinical Pathways spoke with Steve Miller, CMO, Express Scripts, regarding his thoughts on the recently approved gene therapy for acute lymphoblastic leukemia, the accompanying price tag of said therapy, and the challenges the health care system faces paying for gene therapies and making them accessible to patients.

To read the podcast transcript, click here.

Dr Miller recently wrote a blog, "Gene Therapy Holds Great Promise, But Big Price," which this podcast references.